Growth Metrics

UL Solutions (ULS) EBT Margin (2023 - 2026)

Quarterly results put EBT Margin at 17.02% for Q1 2026, up 369.0% from a year ago — trailing twelve months through Mar 2026 was 16.26% (up 125.0% YoY), and the annual figure for FY2025 was 15.39%, up 93.0%.

UL Solutions has reported EBT Margin over the past 4 years, most recently at 17.02% for Q1 2026.

  • EBT Margin reached 17.02% in Q1 2026 per ULS's latest filing, up from 13.31% in the prior quarter.
  • Across five years, EBT Margin topped out at 18.65% in Q3 2025 and bottomed at 10.9% in Q1 2024.
  • Median EBT Margin over the past 4 years was 13.33% (2025), compared with a mean of 14.42%.
  • The largest annual shift saw EBT Margin skyrocketed 477bps in 2024 before it tumbled -225bps in 2025.
  • Over 4 years, EBT Margin stood at 11.55% in 2023, then grew by 8bps to 12.45% in 2024, then increased by 7bps to 13.31% in 2025, then grew by 28bps to 17.02% in 2026.
  • Business Quant data shows EBT Margin for ULS at 17.02% in Q1 2026, 13.31% in Q4 2025, and 18.65% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Relx 81.40 Bn 81.16 Bn - -
2 Rentokil Initial 79.56 Bn 78.10 Bn - 4.78%
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 22.26%
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn 39.32%
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn 17.02%
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn -7.56%
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn 14.03%
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn 2.80%
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn 2.24%
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 30.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.02%
Dec 31, 2025 13.31%
Sep 30, 2025 18.65%
Jun 30, 2025 16.11%
Mar 31, 2025 13.33%
Dec 31, 2024 12.45%
Sep 30, 2024 15.87%
Jun 30, 2024 18.36%
Mar 31, 2024 10.90%
Dec 31, 2023 11.55%
Sep 30, 2023 11.09%
Jun 30, 2023 17.42%
Mar 31, 2023 11.45%